DRMA is Dermata Therapeutics, Inc. Common Stock (Healthcare) — a non-dividend-paying stock. Trading at $1.23. Market cap: $6M. Capital Quality Rank: 14/100 — Capital destroyer.
Stock snapshot
| Price | $1.23 |
| Market cap | $6M |
| Sector | Healthcare |
| Exchange | — |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 14 / 100 · Capital destroyer |
| Shareholder buyback yield | -15.10% |
| Altman Z-score zone | Distress |
About DRMA
Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.
Related non-dividend companies
Other non-dividend stocks investors research alongside DRMA. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is DRMA's current stock price?
DRMA (Dermata Therapeutics, Inc. Common Stock) is currently trading at $1.23.
Does DRMA pay a dividend?
DRMA (Dermata Therapeutics, Inc. Common Stock) does not currently pay a regular dividend.
What is DRMA's Capital Quality Rank?
DRMA has a Capital Quality Rank of 14/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track DRMA in DiviDrip
Add DRMA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search DRMA and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed recently. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.